Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NZOZ Wroclawskie Centrum Alzheimerowskie

Research site

Poland ul. gen. Wladyslawa Sikorskiego 7GHJ, 53-659 Wroclaw, Poland

  • Dementia Alzheimer's type · Dementia of the Alzheimer's type uncomplicated · Prodromal Alzheimer's disease
  • Adult patients

About Specializations

NZOZ Wroclawskie Centrum Alzheimerowskie in Wroclaw, Poland specialises in clinical trials of conditions such as Dementia Alzheimer's type, Dementia of the Alzheimer's type uncomplicated, Prodromal Alzheimer's disease, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases – Alzheimer’s Research

The centre specializes in Alzheimer’s disease. This condition falls under the category of Nervous System Diseases. Current studies evaluate the efficacy of AR1001 in early‑stage patients. Other trials assess safety and biomarker impact of RO7269162 and the multiple‑ascending‑dose profile of RO7126209.

  • Evaluation of AR1001 efficacy in early Alzheimer’s disease
  • Safety and tolerability of RO7269162 with focus on amyloid biomarkers
  • Multiple ascending dose investigation of RO7126209 in prodromal to mild‑moderate stages

Located at NZ O Z Wroclawskie Centrum Alzheimerowskie in Wroclaw, Poland, the centre has initiated three clinical trials under the guidance of a single investigator.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. gen. Wladyslawa Sikorskiego 7GHJ53-659 WroclawPoland
Open in maps ↗
Recruiting now
no trials
Conditions studied
3

More sites in WroclawPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Dementia Alzheimer's type

Not recruiting

Study of RO7126209 safety and effects given by intravenous infusion in patients with early stage or mild to moderate Alzheimer's disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Flortaucipir (18F)
  • Sponsor:F. Hoffmann-La Roche AG

Prodromal Alzheimer's disease

Not recruiting

Study of RO7269162 in people at risk for or with early-stage Alzheimer's Disease: Effects on brain amyloid buildup

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:F. Hoffmann-La Roche AG

Dementia Alzheimer's type

Not recruiting

Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Mirodenafil Dihydrochloride
  • Sponsor:Aribio Co. Ltd.

Dementia of the Alzheimer's type uncomplicated

Not recruiting

Study of XPro1595 for Patients with Early Alzheimer's Disease and Inflammation Markers

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pegipanermin
  • Sponsor:Inmune Bio Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.